Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grupos

Publicaciones

  • Mutch, D; Gaffney, D; Matias-Guiu, X; Fotopoulou, C; Concin, N; Berek, JS

    Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification

    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 165 1304-1305. .

    [doi:10.1002/ijgo.15478]

  • León-Mengibar, J; Sánchez, E; Herrerías, F; de la Fuente, MC; Santamaría, M; Valdivielso, JM; Bermúdez-López, M; Castro, E; Pallarés, J; Matias-Guiu, X; VILARDELL, F; Caixàs, A; Bueno, M; Marti, R; Lecube, A

    Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology 15 1366015-1366015. .

    [doi:10.3389/fendo.2024.1366015]

  • Gaffney, D; Matias-Guiu, X; Mutch, D; Scambia, G; Creutzberg, C; Fotopoulou, C; Berek, JS; Concin, N

    2023 FIGO staging system for endometrial cancer: The evolution of the revolution

    GYNECOLOGIC ONCOLOGY 184 245-253. .

    [doi:10.1016/j.ygyno.2024.02.002]

  • Ledermann, JA; Matias-Guiu, X; Amant, F; Concin, N; Davidson, B; Fotopoulou, C; González-Martin, A; Gourley, C; Leary, A; Lorusso, D; Banerjee, S; Chiva, L; Cibula, D; Colombo, N; Croce, S; Eriksson, AG; Falandry, C; Fischerova, D; Harter, P; Joly, F; Lazaro, C; Lok, C; Mahner, S; Marmé, F; Marth, C; McCluggage, WG; McNeish, IA; Morice, P; Nicum, S; Oaknin, A; Pérez-Fidalgo, JA; Pignata, S; Ramirez, PT; Ray-Coquard, I; Romero, I; Scambia, G; Sehouli, J; Shapira-Frommer, R; Sundar, S; Tan, DSP; Taskiran, C; van Driel, WJ; Vergote, I; Planchamp, F; Sessa, C; Fagotti, A

    ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    ANNALS OF ONCOLOGY 35 248-266. .

    [doi:10.1016/j.annonc.2023.11.015]

  • Santoro, A; Bragantini, E; Castiglione, F; Ganesan, R; Matias-Guiu, X; Frattini, M; Gallotta, V; Garcia, P; Pattni, Y; Tsiampali-Laprell, J; Bisaro, B; Barbareschi, M; Zannoni, GF

    Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs

    Pathologica 116 32-45. .

    [doi:10.32074/1591-951X-926]

  • Matias-Guiu, X; Hoefler, G

    Editorial: Molecular pathology as basis for timely cancer diagnosis and therapy

    VIRCHOWS ARCHIV 484 151-154. .

    [doi:10.1007/s00428-024-03767-y]

  • Concin N; Matias-Guiu X; Fotopoulou C; Creutzberg C; Mutch D; Gaffney D; Lindemann K; Kehoe S; Berek JS

    Response: FIGO staging of endometrial cancer 2023.

    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 164 369-372. .

    [doi:10.1002/ijgo.15277]

  • Albertí-Valls M; Megino-Luque C; Macià A; Gatius S; Matias-Guiu X; Eritja N

    Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.

    Cancers 16 -. .

    [doi:10.3390/cancers16010185]

  • Gatius S; Matias Guiu X; Davidson B

    Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium.

    VIRCHOWS ARCHIV 484 339-351. .

    [doi:10.1007/s00428-023-03710-7]

  • Ruiz-Mitjana, A; Vidal-Sabanés, M; Navaridas, R; Perramon-Güuell, A; Yeramian, A; Nicholson-Sabate, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X

    Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-ß and p38/ERK MAPK signalling

    BIOMEDICINE & PHARMACOTHERAPY 168 115817-115817. .

    [doi:10.1016/j.biopha.2023.115817]

  • Peñalver-Piñol, A; Benavente, Y; Frias-Gomez, J; Alguacil, J; Santibañez, M; Contreras-Llanes, M; Peremiquel-Trillas, P; López-Querol, M; Paytubi, S; Pelegrina, B; Onieva, I; Martínez, JM; Fernandez-Gonzalez, S; de Francisco, J; Caño, V; Brunet, J; Pineda, M; Ponce, J; Matias-Guiu, X; Bosch, FX; de Sanjosé, S; Alemany, L; Costas, L

    Occupational exposure to pesticides and endometrial cancer in the Screenwide case-control study

    Environmental Health 22 -. .

    [doi:10.1186/s12940-023-01028-0]

  • Vergote I; Matias-Guiu X

    New FIGO 2023 endometrial cancer staging validation. Welcome to the first molecular classifiers and new pathological variables!

    EUROPEAN JOURNAL OF CANCER 193 113318-113318. .

    [doi:10.1016/j.ejca.2023.113318]

Proyectos

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU